COVID-19 Vaccine
This track will focus on the development and impact of COVID-19 vaccines. It will review the latest updates on vaccine efficacy, booster shots, and responses to emerging variants. The session will also address lessons learned and future implications for vaccine strategy.
- COVID-19
- booster shots
- vaccine impact
- variants
Related Conference of COVID-19 Vaccine
March 24-25, 2026
9th International Conference on Vaccines, Immunology and Clinical Trials
Paris, France
August 27-28, 2026
7th International conference on Vaccines, Vaccination and Immunization
Paris, France
COVID-19 Vaccine Conference Speakers
Recommended Sessions
- AI & Big Data in Vaccine Research
- Antimicrobial Resistance (AMR)
- Cancer Vaccines and Immunotherapy
- Clinical Trials
- COVID-19 Vaccine
- Emerging Infectious Disease Vaccines
- Global Vaccine Equity
- HIV Vaccines
- Infectious and Non-Infectious Diseases
- Influenza & Respiratory Virus Vaccines
- mRNA Vaccine Innovations
- Novel Adjuvants & Delivery Systems
- One Health: Zoonotic Disease Vaccines
- Pediatric Vaccines: Trends & Future
- Personalized Vaccinology
- Regulatory Pathways in Vaccines
- Vaccine Hesitancy & Public Engagement
- Vaccine Manufacturing Advances
- Vaccine Research & Development
- Vaccine Safety & Immunogenicity
- Vaccine-Preventable Diseases
- Vaccines Epidemiology & Immunology
- Veterinary Vaccine
Related Journals
Are you interested in
- Adaptive Immunity and Immune Memory Formation - WORLD VACCINES 2026 (France)
- Adjuvants and Immune Modulation Strategies - WORLD VACCINES 2026 (France)
- Advancements in Vaccine Research and Development - Vaccines R&D 2026 (France)
- Advances in Pediatric Vaccines - Vaccines R&D 2026 (France)
- Adverse reactions to the vaccination - Vaccines Congress-2026 (UK)
- Animal & Plant Derived Vaccines - Vaccines-Immunization-2026 (France)
- Animal Models & Clinical Trials - Vaccines-Immunization-2026 (France)
- Antibodies: Engineering & Therapeutics - Vaccines-Immunization-2026 (France)
- Antinatal vaccinations - Vaccines Congress-2026 (UK)
- Bacterial Vaccines and Toxoid Development - WORLD VACCINES 2026 (France)
- Cancer, Malaria & TB Vaccines - Vaccines-Immunization-2026 (France)
- Cellular Immunology & Latest Innovations - Vaccines-Immunization-2026 (France)
- Clinical Trials Design and Methodologies - Vaccines R&D 2026 (France)
- Combination & Conjugate Vaccines - Vaccines-Immunization-2026 (France)
- Computational Immunology and Vaccine Modeling - WORLD VACCINES 2026 (France)
- Conjugated and combination vaccinations - Vaccines Congress-2026 (UK)
- Creation and development of vaccines - Vaccines Congress-2026 (UK)
- Current Research & Future Challenges - Vaccines-Immunization-2026 (France)
- DNA & Synthetic Vaccines - Vaccines-Immunization-2026 (France)
- DNA, RNA & SYNTHETIC VACCINES - Vaccines Congress-2026 (UK)
- Emerging and Re-Emerging Infectious Diseases - WORLD VACCINES 2026 (France)
- Emerging Infectious Diseases and Vaccine Development - Vaccines R&D 2026 (France)
- Ethical Considerations in Vaccine Development and Distribution - Vaccines R&D 2026 (France)
- Fish & Poultry Vaccines - Vaccines-Immunization-2026 (France)
- Future Directions in Vaccines and Immunology - WORLD VACCINES 2026 (France)
- Geriatric Immunization - Vaccines-Immunization-2026 (France)
- Global Immunization Strategies and Policy - Vaccines R&D 2026 (France)
- HIV , Malaria & TB vaccines - Vaccines Congress-2026 (UK)
- HIV Vaccines - Vaccines-Immunization-2026 (France)
- Immunogenetics and Host Immune Variability - WORLD VACCINES 2026 (France)
- Immunology of Infectious Diseases - Vaccines R&D 2026 (France)
- Immunopathology and Vaccine Safety - WORLD VACCINES 2026 (France)
- Immunotherapy and Personalized Medicine - Vaccines R&D 2026 (France)
- Innate Immune Responses in Vaccination - WORLD VACCINES 2026 (France)
- Innovations in Vaccine Cold Chain and Storage - Vaccines R&D 2026 (France)
- mRNA Vaccines and Nucleic Acid Platforms - WORLD VACCINES 2026 (France)
- Mucosal Immunity and Alternative Vaccine Routes - WORLD VACCINES 2026 (France)
- Paediatric Vaccination - Vaccines-Immunization-2026 (France)
- Pediatric and Geriatric Immunization Strategies - WORLD VACCINES 2026 (France)
- rDNA technology in vaccine development - Vaccines Congress-2026 (UK)
- Recent advances in vaccine development - Vaccines Congress-2026 (UK)
- Regulatory Approaches in Vaccine Development - Vaccines R&D 2026 (France)
- Regulatory Science and Vaccine Approval Pathways - WORLD VACCINES 2026 (France)
- Role of Adjuvants in Vaccine Efficacy - Vaccines R&D 2026 (France)
- Role of AI and Big Data in Vaccine Research - Vaccines R&D 2026 (France)
- The COVID-19 vaccine's next-generation RNA platforms and mRNA - Vaccines Congress-2026 (UK)
- Toxoid vaccination - Vaccines Congress-2026 (UK)
- Translational Immunology and Vaccine Development - Vaccines R&D 2026 (France)
- Translational Vaccinology from Research to Practice - WORLD VACCINES 2026 (France)
- Travel & Edible Vaccines - Vaccines-Immunization-2026 (France)
- Vaccine and Vaccination - Vaccines Congress-2026 (UK)
- Vaccine Biomarkers and Immune Correlates - WORLD VACCINES 2026 (France)
- Vaccine Delivery Systems and Targeting Approaches - WORLD VACCINES 2026 (France)
- Vaccine Delivery Systems: Innovations and Challenges - Vaccines R&D 2026 (France)
- Vaccine Design and Antigen Engineering - WORLD VACCINES 2026 (France)
- Vaccine Development for Cancer Immunotherapy - Vaccines R&D 2026 (France)
- Vaccine Development for Vector-Borne Diseases - Vaccines R&D 2026 (France)
- Vaccine efficiency and well-being - Vaccines Congress-2026 (UK)
- Vaccine Equity and Access in Low-Resource Settings - Vaccines R&D 2026 (France)
- Vaccine for infectious illnesses in humans - Vaccines Congress-2026 (UK)
- Vaccine Hesitancy and Public Perception - Vaccines R&D 2026 (France)
- Vaccine Manufacturing and Distribution - Vaccines R&D 2026 (France)
- Vaccine Manufacturing and Scale-Up Technologies - WORLD VACCINES 2026 (France)
- Vaccine manufacturing technologies - Vaccines Congress-2026 (UK)
- Vaccine Production & Development - Vaccines-Immunization-2026 (France)
- Vaccine Research and Clinical trials - Vaccines Congress-2026 (UK)
- Vaccine Safety and Pharmacovigilance - Vaccines R&D 2026 (France)
- Vaccine-Induced Cellular Immunity - WORLD VACCINES 2026 (France)
- Vaccines - Vaccines-Immunization-2026 (France)
- Vaccines & Autism - Vaccines-Immunization-2026 (France)
- Vaccines against Drugs - Vaccines-Immunization-2026 (France)
- Vaccines against Infectious Diseases - Vaccines-Immunization-2026 (France)
- Vaccines against non-traditional illnesses - Vaccines Congress-2026 (UK)
- VACCINES FOR CANCER - Vaccines Congress-2026 (UK)
- Vaccines for Immune Mediated Diseases - Vaccines-Immunization-2026 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines-Immunization-2026 (France)
- Vaccines for Unconventional Diseases - Vaccines-Immunization-2026 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines-Immunization-2026 (France)
- Viral Vaccine Platforms and Vector Technologies - WORLD VACCINES 2026 (France)
- Zika Virus vaccines - Vaccines Congress-2026 (UK)